Navigation Links
Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Date:7/16/2008

r implied by such statements. These risks and uncertainties include, without limitation, the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost- containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; economic conditions including interest and currency exchange rate fluctuations; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2007, which was filed with the Securities and Exchange Commission on February 29, 2008. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
2. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
3. Wyeth Declares Common and Preferred Stock Dividends
4. Wyeth Pharmaceuticals Announces Organizational Change
5. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
6. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
7. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
8. Wyeth Chairman Robert Essner Announces June 27 Retirement
9. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
10. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
11. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YourEncore, an Indianapolis, Indiana-based company that ... and food sciences industries solve complex development, regulatory ... Research Excellence and Safety (ACRES), a Massachusetts-based non-profit ... have partnered to speed innovation in the medical ... to ACRES experts with proven experience, tools, and ...
(Date:4/20/2015)... , April 20, 2015  Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal and metabolic diseases, today ... has joined the Company,s Board of Directors. Dr. ... board level experience, having built and led teams ... regulatory approval and into healthcare systems globally. ...
(Date:4/20/2015)... , April 20, 2015 /CNW/ - Portage Biotech ... Securities Exchange: PBT.U), is pleased to announce that its ... a collaborative research study that showed one of its ... inflammation in brain tissue through inhibition of NFkB signalling ... The permeability of the blood brain barrier ...
(Date:4/18/2015)... Aurigene and its partner ... presenting data at the poster sessions from two ... Annual Meeting (April 18-22 in Philadelphia, ... http://photos.prnewswire.com/prnh/20130418/608115 ) , Aurigene will present ... molecule inhibitors program, which is currently in preclinical ...
Breaking Biology Technology:YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2
... REDWOOD CITY, Calif., Feb. 17, 2011 Codexis, Inc. (Nasdaq: ... U.S. Senator from North Dakota, has been elected to the ... in January 2011 after a 30-year career in the U.S. ... "We are very pleased to welcome Byron Dorgan to our ...
... Healthcare has announced the formation of a Medical Advisory ... Director is Dr. Armand B. Cognetta, distinguished Dermatologist and ... is recognized as a leader and innovator in his ... advocacy in the ongoing development of the Company,s leading ...
... LA JOLLA, Calif., Feb. 17, 2011 CalciMedica, ... inflammatory and autoimmune diseases, today announced that it ... 1 clinical trial of CM2489. CM2489 is a ... studied as a once-daily oral therapeutic for patients ...
Cached Biology Technology:Former Senator Byron Dorgan Elected to Codexis Board 2Sensus Healthcare Announces the Formation of a Medical Advisory Board 2CalciMedica Initiates Phase I Clinical Trial of First CRAC Channel Inhibitor (CCI) for Psoriasis 2
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... is always a delicate affair. Few researchers, however, ... whose working laboratory aboard the International Space Station ... Earth, traveling at some 17,000 miles per hour. ... University,s Biodesign Institute, is using the ISS platform ...
... PA. -- While most farmers consider viruses and fungi ... wild plants adapt to extreme conditions, according to a ... the hardiness of plants is a key to sustainable ... addition to avoiding possible conflicts over scare resources, said ...
... not translated into proteinare key to physically manipulating DNA in ... Institute. These non-coding RNA-activators (ncRNA-a) have a crucial role in ... say, and have also been connected with diseases, including some ... article of the journal Nature , a team of ...
Cached Biology News:International space station plays host to innovative infectious disease research 2International space station plays host to innovative infectious disease research 3International space station plays host to innovative infectious disease research 4International space station plays host to innovative infectious disease research 5International space station plays host to innovative infectious disease research 6Microbes team up to boost plants' stress tolerance 2'Activating' RNA takes DNA on a loop through time and space 2'Activating' RNA takes DNA on a loop through time and space 3
... This CE-based system provides clear advantages ... (viral load, gene expression), mutation analysis, ... easy-to-use system with microplate connectivity is ... and quality control. The P/ACE ...
The imaging screen-K (Kodak), tritium, is a 20 x 25 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
The filter 640DF35 for the Molecular Imager FX is a band pass filter for Texas Red dye....
Biology Products: